(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of 7.76% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Azenta's revenue in 2024 is $641,023,000.On average, 4 Wall Street analysts forecast AZTA's revenue for 2024 to be $39,324,179,074, with the lowest AZTA revenue forecast at $39,202,889,905, and the highest AZTA revenue forecast at $39,569,824,493. On average, 3 Wall Street analysts forecast AZTA's revenue for 2025 to be $41,389,998,500, with the lowest AZTA revenue forecast at $41,154,669,630, and the highest AZTA revenue forecast at $41,545,025,575.
In 2026, AZTA is forecast to generate $43,819,127,780 in revenue, with the lowest revenue forecast at $43,528,033,776 and the highest revenue forecast at $44,110,221,785.